COPB2 promotes hepatocellular carcinoma progression through regulation of YAP1 nuclear translocation
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Coatomer protein complex subunit beta 2 (COPB2) and Yes-associated protein 1 (YAP1) impact hepatocellular carcinoma (HCC) drug sensitivity. Targeting COPB2/YAP1 may offer new precision treatment strategies for HCC patients.
Area Of Science
- Oncology
- Molecular Biology
- Cancer Research
Background
- Yes-associated protein 1 (YAP1) is a known oncogene in hepatocellular carcinoma (HCC).
- The role and mechanism of coatomer protein complex subunit beta 2 (COPB2) in HCC are not fully understood.
- Investigating the interplay between COPB2 and YAP1 is crucial for understanding HCC progression.
Purpose Of The Study
- To investigate the role of COPB2 and YAP1 in HCC progression.
- To elucidate the underlying mechanisms of COPB2 in regulating YAP1.
- To assess the prognostic value and therapeutic implications of COPB2 and YAP1 in HCC.
Main Methods
- Analysis of COPB2 and YAP1 expression in HCC tissues using database searches and immunohistochemistry.
- Establishment of prognostic models (nomogram, artificial neural network) based on COPB2 and YAP1 expression.
- In vitro assays including cell proliferation, migration, invasion, immunofluorescence, and Western blot to explore mechanisms.
Main Results
- Combined COPB2 and YAP1 expression is an independent prognostic factor for HCC patients.
- High COPB2 and YAP1 expression may decrease the efficacy of transarterial chemoembolization therapy.
- COPB2 regulates YAP1 nuclear translocation, affecting HCC cell sensitivity to Cisplatin (DDP).
Conclusions
- The COPB2/YAP1 axis influences HCC cell drug sensitivity to DDP.
- Targeting the COPB2/YAP1 pathway presents a potential strategy for precision treatment in HCC.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Three of the best-understood negative regulators are p53, p21, and retinoblastoma protein (Rb). The regulatory roles of each of these proteins were discovered after faulty copies were found in cells with uncontrolled replication (i.e.,...
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...